Wujia Yizhi granules for mild-to-moderate Alzheimer's
Part of Brain & nervous system, Mental health clinical trials.
This trial tests if a Chinese herbal granule (Wujia Yizhi) can help people with mild-to-moderate Alzheimer's dementia. It is for patients who have memory problems for at least 6 months and meet specific Alzheimer's biomarker criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You have been diagnosed with mild-to-moderate Alzheimer's dementia for at least 6 months.
- You have proof of Alzheimer's-related brain changes (from a PET scan or spinal fluid test).
- Your memory and thinking test scores fall within a certain range.
- You do not have other types of dementia, a history of seizures, or active psychiatric conditions.
- You are not currently taking antidepressants, anxiety meds, or antipsychotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial tests whether a medicine called sodium oligomannate (GV-971) is safe and effective for people with mild to moderate Alzheimer’s disease. It may help slow or improve memory and thinking symptoms while carefully tracking side effects.
This trial tests a new medicine, VHB937, in people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow down memory loss and thinking problems.
This trial tests a new drug, NBI-1117567, for people with mild to moderate Alzheimer's disease who are already taking a standard Alzheimer's medication. The goal is to see if the new drug can help improve symptoms.
This trial is testing an experimental medicine called QLH2405 in two groups: healthy volunteers (to check safety) and people with mild memory problems due to Alzheimer's. If you qualify, the study may help find out if this new treatment is safe and could slow down memory decline.
This trial tests whether a supplement called Neuroaid II can help people with mild to moderate Alzheimer's disease. It is a pill taken alongside your usual Alzheimer's treatments, and the study aims to see if it can slow down memory decline.
This study tests whether Huperzine A controlled-release tablets can help improve memory and thinking in people with mild-to-moderate Alzheimer's disease. You'll take the tablets or a placebo to see if it slows down dementia symptoms.
Hear when a new Alzheimer's Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.